User:Mr. Ibrahem/Vonoprazan/amoxicillin/clarithromycin
| Combination of | |
|---|---|
| Vonoprazan | Potassium-competitive acid blocker |
| Amoxicillin | Beta-lactam antibiotic |
| Clarithromycin | Macrolide antibiotic |
| Clinical data | |
| Trade names | Vonosap, Voquezna triple pak |
| AHFS/Drugs.com | Monograph |
| License data | |
| Legal status | |
| Legal status | |
Vonoprazan/amoxicillin/clarithromycin, sold under the brand name Vonosap among others, is a co-packaged medication used to treat Helicobacter pylori (H. pylori) infection.[1] It is taken by mouth.[1]
Common side effects include diarrhea, vaginal yeast infection, headache, abdominal pain, and high blood pressure.[1] Other side effects may include allergic reaction, Clostridioides difficile-associated diarrhea, QT prolongation.[1] Use is generally not recommended in pregnancy.[1] It contains vonoprazan, a potassium-competitive acid blocker; amoxicillin, a beta-lactam antibiotic; and clarithromycin, a macrolide antibiotic.[1]
The combination was approved for medical use in Japan in 2016,[2] and the United States in 2022.[1] In the United States a course of treatment costs about 860 USD as of 2022.[3] As of 2022 it is not avaliable in Europe or the United Kingdom.[4]
References
[change | change source]- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 "Voquezna Dual Pak- vonoprazan fumarate and amoxicillin kit Voquezna Triple Pak- vonoprazan fumarate, amoxicillin and clarithromycin kit". DailyMed. 21 June 2022. Archived from the original on 3 July 2022. Retrieved 3 July 2022.
- ↑ 2.0 2.1 "Vonosap pack 400, Vonosap pack 800 and Vonopion pack (triple-drug blister packs containing Takecab tablet) Now Available for Helicobacter pylori[*] Eradication in Japan". Takeda. 7 June 2016. Archived from the original on 10 May 2022. Retrieved 9 May 2022.
- ↑ "Voquezna Triple Pak Prices, Coupons, Copay & Patient Assistance". Drugs.com. Retrieved 12 December 2022.
- ↑ "Vonoprazan". SPS - Specialist Pharmacy Service. 10 December 2019. Archived from the original on 25 September 2021. Retrieved 12 December 2022.